17May 2020

REVIEW ABOUT THERAPEUTIC AND PROPHYLACTIC EFFECTS OF VITAMIN (D AND E) ON SOME RESPIRATORY VIRAL INFECTIONS, AND COVID 19

  • Clinical Chemistry, College of Medicine, Al-Nahrain University.
  • Chemical Pathology, College of Pharmacy, Al-Nahrain University.
  • Disgnostic and Therapeutic Radiology.University of Granada.
Crossref Cited-by Linking logo

  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Oxidative stress associated with almost all viral infections in other words, inducing immune storm which increase generation of reactive-oxygen species(ROS) that causes damage in small vessels cellular membranes extensively at viral infections durance.Vitamin E considered as one amongmany antioxidants examinedin mice in infections of influenza virus, with a leader position for its ability in blocking oxidative damage by its scavenging activity of free-radical. The phenomenon of Vitamin D multi-directional activity is probablybecause of the existence of theVit. Dreceptors (VDR)sin most human cells of non-skeletal.Also, vit. D able tochange the immunity (acquired and innate) , therefore able to be utilized as preventive, therapeutic adjuvant vaccine, for many viral infections difficultly to treat like influenza virus, and course modulating therapy for oral herpes virus, Epstein bar virus, hepatitis B virus, and some respiratory viruses, like covid 19.Retinoic acid has important role in cell differentiation and growth,where vitamin A partially can regulate viral growth. Retinoidsinfluence many of virus infections in different complex ways i.e., ifvariouslines of cellshave an infectionby the human cytomegalic-virus(hCMV), cells exposure to retinoic acid (RA) encouragesexpression of viral nucleic acid with vulnerability to infection.

  1. Jones G. Vitamin D safety: Its mechanisms and application.?Stand. Med. Pediatr.?20129:605?609.
  2. Kim D. The role of vitamin D in thyroid diseases.?Int. J. Mol. Sci.?2017:18.
  3. Beard J.A., Bearden A., Striker R. Vitamin D and the anti-viral state.?J. Clin. Virol.?201150:194?200.
  4. Kienreich K., Gr?bler M., Tomaschitz A., Schmid J., Verheyen N., Rutters F., Dekker J.M., Pilz S. Vitamin D, arterial hypertension & cerebrovascular disease. [(accessed on 23 September 2013)]Indian J. Med. Res.?2013?137:669?679.
  5. Beata M. Gruber-Bzura. Vitamin D and Influenza?Prevention or Therapy? Int J Mol Sci. 2018 Aug 19(8): 2419. Published online 2018 Aug 16.
  6. Bikle D.D. Extraskeletal actions of vitamin D.? N. Y. Acad. Sci.?20161376:29?51.
  7. Greiller C.L., Martineau A.R. Modulation of the immune response to respiratory viruses by vitamin D.??20157:4240?4270.
  8. Kienreich K., Gr?bler M., Tomaschitz A., Schmid J., Verheyen N., Rutters F., Dekker J.M., Pilz S. Vitamin D, arterial hypertension & cerebrovascular disease. [(accessed on 23 September 2013)]Indian J. Med. Res.?2013?137:669?679.?Available online
  9. Odroważ-Sypniewska G., Karczmarewicz E., Paprotny Ł., Płudowski P. 3-epi-25(OH)D?A new metabolite, potential biological function, interference in laboratory assays.? Med. Pediatr.?20129:680?686.
  10. McCullough P., Amend J. Results of daily oral dosing with up to 60,000 international units (iu) of vitamin D3 for 2 to 6 years in 3 adult males.? Steroid Biochem. Mol. Biol.?2017173:308?312.
  11. Christakos S., Hewison M., Gardner D.G., Wagner C.L., Sergeev I.N., Rutten E., Pittas A.G., Boland R., Ferrucci L., Bikle D.D. Vitamin D: Beyond bone.? N. Y. Acad. Sci.?20131287:45?58.
  12. Moukayed M., Grant W.B. Molecular link between vitamin D and cancer prevention.??20135:3993?4021
  13. .?Lorenc R.S., Karczmarewicz E., Kryśkiewicz E., Płudowski P. Vitamin D provision and supplementation standards.? Med. Pediatr.?20129:595?604.
  14. Abdelsalam A., Rashed L., Salman T., Hammad L., Sabry D. Molecular assessment of vitamin D receptor polymorphism as a valid predictor to the response of interferon/Ribavirin based therapy in Egyptian patients with Chronic Hepatitis C.? Dig. Dis.?201617:547?553.
  15. Lange C.M., Bojunga J., Ramos-Lopez E., von Wagner M., Hassler A., Vermehren J., Herrmann E., Badenhoop K., Zeuzem S., Sarrazin C. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy.? Hepatol.?201154:887?893.
  16. Xue L.N., Xu K.Q., Zhang W., Wang Q., Wu J., Wang X.Y. Associations between vitamin D receptor polymorphisms and susceptibility to ulcerative colitis and Crohn?s disease: A meta-analysis.? Bowel Dis.?201319:54?60.
  17. Misiorowski W. Vitamin D in type 1 and type 2 diabetes in adulthood.? Med. Pediatr.?20129:639?644.
  18. Holick C.N., Stanford J.L., Kwon E.M., Ostrander E.A., Nejentsev S., Peters U. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP28B1, and CYP24A1, in prostate cancer.?Cancer Epidemiol. Biomark. Prev.?200716:1990?1999.
  19. Areeshi M.Y., Mandal R.K., Akhter N., Panda A.K., Haque S. Evaluating the association between TaqI variant of vitamin D receptor gene and susceptibility to tuberculosis: A meta-analysis.? Int.?201421:140?147.
  20. Pittas A.G., Laskowski U., Kos L., Saltzman E. The role of vitamin D In adults requiring nutrition therapy.? Parenter. Enteral Nutr.?201034:70?78.
  21. Bischoff-Ferrari H.A., Shao A., Dawson-Hughes B., Hathcock J., Giovanucci E., Willet W.C. Benefit-risk assessment of vitamin D supplementation.? Int.?201021:1121?1132.
  22. Heaney R.P. Vitamin D in health and disease.? J. Am. Soc. Nephrol.?20083:1535?1541.
  23. Dougherty K.A., Schall J.J., Zemel B.S., Tuluc F., Hou X., Ritstein R.M., Stallings V.A. Safety and efficacy of high-dose daily vitamin D3?supplementation in children and young adult infected with human immunodeficiency virus.? Pediatr. Infect. Dis. Soc.?20143:294?303.
  24. Cashman K.D., Ritz C., Kely M. ODIN Collaborators. Improved dietary guidelines for vitamin D: Application of individual participant data (IPD)-level meta-regression analyses.??20179:469.
  25. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., Garland C.F., Giovannucci E. Epidemic influenza and vitamin D.? Infect.?2006134:1129?1140.
  26. Sundaram M.E., Coleman L.A. Vitamin D and influenza.? Nutr.?20123:517?525.
  27. Szymczak I., Pawliczak R. The active metabolite of vitamin D3?as a potential immunomodulator.? J. Immunol.?201583:83?91.
  28. Jak?bisiak M.??2nd ed. WydawnictwoNaukowe PWN Warsaw, Poland: 1995. Gł?wnekomponentyizasadniczecechyodpowiedziimmunologicznej pp. 28?36.
  29. Bruce D., Ooi J.H., Yu S., Cantorna M.T. Vitamin D and host resistance to infection? Putting the cart in front of the horse.? Biol. Med.?2010235:921?927.
  30. Chun R.F., Liu P.T., Modlin R.L., Adams J.S., Hewison M. Impact of vitamin D on immune function: Lessons learned from genome-wide analysis.? Physiol.?20145:1?15.
  31. Fitch N., Becker A.B., HayGlass K.T. Vitamin D[1,25[OH]2D3] differentially regulates human innate cytokine responses to bacterial versus viral pattern recognition receptor stimuli.? Immunol.?2016196:2965?2972.
  32. Jasińska J. The role of receptor CD40-ligand CD40 (cd40/D40L) system in inflammatory processes.??20154:39?42.
  33. Jeffery L.E., Wood A.M., Qureshi O.S., Hou T.Z., Gardner D., Briggs Z., Kaur S., Raza K., Sansom D.M. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses.? Immunol.?2012189:5155?5164
  34. Sigmundsdottir H., Pan J., Debes G.F., Alt C., Habtezion A., Soler D., Butcher E.C. DCs metabolize sunlight-induced vitamin D3 to ?program? T cell attraction to the epidermal chemokine CCL27.? Immunol.?20078:285?293.
  35. Amital H., Shoenfeld Y. Disease associations of vitamin D in autoimmune disorders-prevention and therapy.? Med. Pediatr.?20129:620?622.
  36. Tang J., Zhou R., Luger D., Zhu W., Silver P.B., Grajewski R.S., Su S.B., Chan C.C., Adorini L., Caspi R.R. Calcitriol suppresses antirenal autoimmunity through inhibitory effects on the Th17 effector response.? Immunol.?2009182:4624?4632.
  37. Ehrchen J., Helming L., Varga G., Pasche B., Loser K., Gunzer M., Sunderk?tter C., Sorg C., Roth J., Lengeling A. Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major.?FASEB J.?200721:3208?3218.
  38. Rajapakse R., Mousli M., Pfaff A.W., Uring-Lambert B., Marcellin L., Bronner C., Jeanblanc M., Villard O., Letscher-Bru V., Klein J.P., et al. 1,25-dihydroxyvitamin D3 induces splenocyte apoptosis and enhances BALB/c mice sensitivity to toxoplasmosis.? Steroid Biochem. Mol. Biol.?200596:179?185
  39. Ryz N.R., Patterson S.J., Zhang Y., Ma C., Huang T., Bhinder G., Wu X., Chan J., Glesby J., Sham H.P., et al. Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacterrodentium by suppressing mucosal Th17 responses.? J. Ohysiol. Gastrointest. Liver Physiol.?2012303:G1299?G1311.
  40. Fang Y., Banner D., Kelvin A.A., Huang S.S., Paige C.J., Corfe S.A., Kane K.P., Bleackley R.C., Rowe T., Leon A.J., et al. Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell dependent mechanism.? Virol.?201286:2229?2238.
  41. Shiozawa K., Shiozawa S., Shimizu S., Fujita T. 1α,25-dihydroxyvitamin D3?inhibits pokeweed mitogen-stimulated human B-cell activation: An analysis using serum-free culture conditions.??198556:161?167.
  42. Shirakawa A.-K., Nagakubo D., Hieshima K., Nakayama T., Jin Z., Yoshie O. 1,25-Dihydroxyvitamin D3 Induces CCR10 Expression in Terminally Differentiating Human B Cells.? Immunol.?2008180:2786?2795.
  43. Heine G., Niesner U., Chang H.D., Steinmeyer A., Z?gel U., Zuberbier T., Radbruch A., Worm M. 1,25-dihydroxyvitamin D3promotes IL-10 production in human B cells.? J. Immunol.?200838:2210?2218.
  44. Penna G., Amuchastegui S., Cossetti C., Aquilano F., Mariani R., Sanvito F., Doglioni C., Adorini L. Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol.? Immunol.?2006177:8504?8511.
  45. Langrish L.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.? Exp. Med.?2005201:233?240
  46. Friis H., Range N., Pedersen M.L., M?lgaard C., Changalucha J., Krarup H., Magnussen P., S?borg C., Andersen A.B. Hypovitaminosis D is common among pulmonary tuberculosis patients in Tanzania but is not explained by the acute phase response.? Nutr.?2008138:2474?2480
  47. Tse A.K., Wan C.K., Shen X.L., Zhu G.Y., Cheung H.Y., Yang M., Fong W.F. 1,25-dihydroxyvitamin D3 induces biphasic NF-kappaB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IκB.? Cell Res.?2007313:1722?1734.
  48. J. Cannell, R. Vieth, J. C. Umhau et al., ?Epidemic influenza and vitamin D,?Epidemiology and Infection, vol. 134, no. 6, pp. 1129?1140, 2006.
  49. J. Cannell, R. Vieth, W. Willett et al., ?Cod liver oil, vitamin A toxicity, frequent respiratory infections, and the vitamin D deficiency epidemic,?Annals of Otology, Rhinology and Laryngology, vol. 117, no. 11, pp. 864?870, 2008.
  50. J. Cannell, M. Zasloff, C. F. Garland, R. Scragg, and E. Giovanucci, ?On the epidemiology of influenza,?Virology Journal, vol. 5, article 29, 2008.
  51. Srivastava, P. Błazejewska, M. Hessmann et al., ?Host genetic background strongly influences the response to influenza a virus infections,?PLoS One, vol. 4, no. 3, Article ID e4857, 2009.
  52. Hoffmann and G. Eichele, ?Retinoids in development, in?The Retinoids: Biology, Chemistry, and Medicine, M. B. Sporn, A. B. Roberts, and D. S. Goodman, Eds., pp. 387?441, Raven Press, New York, NY, USA, 1994.
  53. Theodosiou, V. Laudet, and M. Schubert, ?From carrot to clinic: an overview of the retinoic acid signaling pathway,?Cellular and Molecular Life Sciences, vol. 67, no. 9, pp. 1423?1445, 2010.
  54. A. Lane and S. J. Bailey, ?Role of retinoid signalling in the adult brain,?Progress in Neurobiology, vol. 75, no. 4, pp. 275?293, 2005.
  55. Litwack, Ed.,?Vitamin A: Vitamins and Hormones, vol. 75, Elsevier Academic Press, San Diego, Calif, USA, 2007.
  56. Manicassamy and B. Pulandran, ?Retinoic acid-dependent regulation of immune responses by dentritic cells and macrophage,?SeminImmunol, vol. 21, pp. 22?27, 2009.
  57. Pfahl and F. Chytil, ?Regulation of metabolism by retinoic acid and its nuclear receptors,?Annual Review of Nutrition, vol. 16, pp. 257?283, 1996.
  58. B. Nilsson and H. H?kansson, ?The retinoid signaling system?a target in dioxin toxicity,?Critical Reviews in Toxicology, vol. 32, no. 3, pp. 211?232, 2002.
  59. Blomhoff and H. K. Blomhoff, ?Overview of retinoid metabolism and function,?Journal of Neurobiology, vol. 66, no. 7, pp. 606?630, 2006.
  60. J. Fisher, S. Datta, Z. Wang et al., ?c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid,?Journal of Clinical Investigation, vol. 106, no. 5, pp. 663?670, 2000.
  61. T. Schug, D. C. Berry, N. S. Shaw, S. N. Travis, and N. Noy, ?Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors,?Cell, vol. 129, no. 4, pp. 723?733, 2007.
  62. A. Leo and C. S. Lieber, ?New pathway for retinol metabolism in liver microsomes,?Journal of Biological Chemistry, vol. 260, no. 9, pp. 5228?5231, 1985.
  63. Maden and M. Hind, ?Retinoic acid in alveolar development, maintenance and regeneration,?Philosophical Transactions of the Royal Society, vol. 359, no. 1445, pp. 799?808, 2004.
  64. L. Penniston and S. A. Tanumihardjo, ?The acute and chronic toxic effects of vitamin A,?American Journal of Clinical Nutrition, vol. 83, no. 2, pp. 191?201, 2006.
  65. A. Olson, ?Vitamin A?functions, dietary requirements and safety in humans, in?Present Knowledge in Nutrition, E. E. Ziegler and L. J. Filer Jr., Eds., pp. 109?119, International Life Sciences Institute Press, Washington, DC, USA, 7th edition, 2001.
  66. Institute of Medicine,?Food and Nutrition-Based Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Iron, Molybdenum, Nickel, Silicon, Vanadium, and Zinc, National Academy Press, Washington, DC, USA, 2001
  67. MilkaMileva, Angel S. Galabov.? ?Vitamin E and Influenza Virus Infection .? Vitamin E in health and disease book. Submitted: February 9th 2018 Reviewed: August 16th 2018 Published: October 24th 2018.
  68. S. Hui, E. IA, T.A. Madani, F. Ntoumi, R. Kock, O. Dar, et al.The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China Int. J. Infect. Dis., 91 (2020), pp. 264-266
  69. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, et al.Genomiccharacterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 395 (10224) (2020), pp. 565-574,
  70. L. Ren, Y.M. Wang, Z.Q. Wu, Z.C. Xiang, L. Guo, T. Xu, et al.Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chinese Med J (2020).
  71. Cui, F. Li, Z.L. ShiOrigin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol., 17 (2019), pp. 181-192.
  72. Zhu, D. Zhang, W. Wang, X. Li, B. Yang, J. Song, et al.A novel coronavirus from patients with pneumonia in China N. Engl. J. Med., 382 (2019), pp. 727-733.
  73. Wan, J. Shang, R. Graham, R.S. Baric, F. LiReceptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J. Virol. (2020),
  74. A. Jaimes, J.K. Millet, A.E. Stout, N.M. Andre, G.R. WhittakerA tale of two viruses: the distinct spike glycoproteins of feline coronaviruses. Viruses, 12 (2020).
  75. Lei, J. Li, X. Li, X. QiCT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology (2020), p. 200236,
  76. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395 (10223) (2020), pp. 497-506.

[Mohammed I. Hamzah, Israa A. Abdul Kareem and Sabah Hasan Shindakh Nooraldeen (2020); REVIEW ABOUT THERAPEUTIC AND PROPHYLACTIC EFFECTS OF VITAMIN (D AND E) ON SOME RESPIRATORY VIRAL INFECTIONS, AND COVID 19 Int. J. of Adv. Res. 8 (May). 60-74] (ISSN 2320-5407). www.journalijar.com

Mohammed I. Hamzah
Clinical Chemistry, College of Medicine , Al-Nahrain University.

DOI:

Article DOI: 10.21474/IJAR01/10908      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10908

Download Full Paper

Download PDF No. of Downloads: 31 | No. of Views: 75